Pages that link to "Q36952218"

The following pages link to Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. (Q36952218):

Displaying 22 items.

• The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease (Q33831711) (← links)
• Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? (Q39013059) (← links)
• The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment (Q39410610) (← links)
• Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease (Q40181436) (← links)
• Obese children with fatty liver: Between reality and disease mongering (Q47158441) (← links)
• Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD. (Q48024919) (← links)
• Preventing liver fibrosis in patients with NAFLD and the road ahead. (Q49363449) (← links)
• Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease (Q49813492) (← links)
• Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial. (Q51268638) (← links)
• Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014. (Q55027884) (← links)
• Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH (Q61796232) (← links)
• Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates (Q61809313) (← links)
• Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD. (Q64932672) (← links)
• Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease. (Q64988810) (← links)
• Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter (Q88611062) (← links)
• Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis (Q90047443) (← links)
• Sphingosine 1-Phosphate Receptor Blockade Affects Pro-Inflammatory Bone Marrow-Derived Macrophages and Relieves Mouse Fatty Liver Injury (Q90224854) (← links)
• NAFLD in children: new genes, new diagnostic modalities and new drugs (Q91666456) (← links)
• The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children (Q92130499) (← links)
• Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model (Q92861568) (← links)
• Hepatic fibrosis in children and adults (Q93141351) (← links)
• Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials (Q98290725) (← links)